These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21904459)
1. Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease. Bröker M; Cooper B; Detora LM; Stoddard JJ Infect Drug Resist; 2011; 4():137-47. PubMed ID: 21904459 [TBL] [Abstract][Full Text] [Related]
2. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine. Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258 [TBL] [Abstract][Full Text] [Related]
3. Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. Cooper B; DeTora L; Stoddard J Expert Rev Vaccines; 2011 Jan; 10(1):21-33. PubMed ID: 21162617 [TBL] [Abstract][Full Text] [Related]
4. Meningococcal vaccine evolution. Bona G; Guidi C J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617 [TBL] [Abstract][Full Text] [Related]
5. Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Hedari CP; Khinkarly RW; Dbaibo GS Infect Drug Resist; 2014; 7():85-99. PubMed ID: 24729718 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2-18 years in Taiwan: results of an open label study. Huang LM; Chiu NC; Yeh SJ; Bhusal C; Arora AK Vaccine; 2014 Sep; 32(40):5177-84. PubMed ID: 25075804 [TBL] [Abstract][Full Text] [Related]
7. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM; Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study. Knuf M; Romain O; Kindler K; Walther U; Tran PM; Pankow-Culot H; Fischbach T; Kieninger-Baum D; Bianco V; Baine Y; Miller J Eur J Pediatr; 2013 May; 172(5):601-12. PubMed ID: 23307281 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Kimura A; Toneatto D; Kleinschmidt A; Wang H; Dull P Clin Vaccine Immunol; 2011 Mar; 18(3):483-6. PubMed ID: 21177912 [TBL] [Abstract][Full Text] [Related]
10. An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Keshavan P; Pellegrini M; Vadivelu-Pechai K; Nissen M Expert Rev Vaccines; 2018 Oct; 17(10):865-880. PubMed ID: 30198805 [TBL] [Abstract][Full Text] [Related]
11. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants. Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906 [TBL] [Abstract][Full Text] [Related]
12. Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra. Reisinger KS; Baxter R; Block SL; Shah J; Bedell L; Dull PM Clin Vaccine Immunol; 2009 Dec; 16(12):1810-5. PubMed ID: 19812260 [TBL] [Abstract][Full Text] [Related]
13. Use of MenACWY-CRM in adolescents in the United States. Black S; Block SL J Adolesc Health; 2013 Mar; 52(3):271-7. PubMed ID: 23299001 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults. Lee HJ; Chung MH; Kim WJ; Hong YJ; Choi KM; Lee J; Oh CE; Welsch JA; Kim KH; Hong KB; Dagnew AF; Bock H; Dull PM; Odrljin T Int J Infect Dis; 2014 Nov; 28():204-10. PubMed ID: 25316331 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants. Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097 [TBL] [Abstract][Full Text] [Related]
16. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents. Baxter R; Reisinger K; Block SL; Izu A; Odrljin T; Dull P J Pediatr; 2014 Jun; 164(6):1409-15.e4. PubMed ID: 24657122 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents. Saez-Llorens X; Aguilera Vaca DC; Abarca K; Maho E; Graña MG; Heijnen E; Smolenov I; Dull PM Hum Vaccin Immunother; 2015; 11(6):1507-17. PubMed ID: 25969894 [TBL] [Abstract][Full Text] [Related]
18. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults. Pace D Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents. Jackson LA; Jacobson RM; Reisinger KS; Anemona A; Danzig LE; Dull PM Pediatr Infect Dis J; 2009 Feb; 28(2):86-91. PubMed ID: 19116603 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. Stamboulian D; Lopardo G; Lopez P; Cortes-Barbosa C; Valencia A; Bedell L; Karsten A; Dull PM Int J Infect Dis; 2010 Oct; 14(10):e868-75. PubMed ID: 20655261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]